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Introduction
It is not uncommon for infants to suffer from fever
within the first 3 months of life. Although such fevers
are typically self-limiting, it has been reported that
1–38% of afflicted infants also have serious bacterial
infection (SBI).1–8 Traditionally, febrile infants youn-
ger than 90 days of age were hospitalized, received a
full sepsis workup, and were treated with intravenous
antibiotics until definitive culture results became avail-
able.1,9 There are obvious problems with such a treat-
ment strategy in that the majority of young infants
with fever do not have SBI. Therefore, large numbers
of febrile infants continue to receive unnecessary
treatment that is costly, stressful for both infant and
parents, and that may be associated with iatrogenic
complications and antibiotic resistance.10,11 If cor-
rectly identified, such infants could be treated on an
outpatient basis.
Numerous investigations have been carried out in
an effort to identify readily assessable variables that
predict a low or high risk of SBI in young febrile 
infants (for a review on this topic, see reference 12).
Despite this, there currently exists no uniformly
accepted assessment approach. Two popular methods
for assessing SBI risk are the Rochester criteria3 and
the Philadelphia protocol.13 Both include measures of
current and historical physical status as well as several
laboratory variables, including white blood cell (WBC)
count. While these approaches appear to be of use in
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older infants, it is apparent that sensitivity is decreased
in infants less than 1 month of age.14 Other researchers
have reported that levels of C-reactive protein (CRP),
absolute neutrophil count and procalcitonin can be
indicative of SBI risk.10,15–17
In our pediatric department, standard handling of
young infants with fever comprises hospitalization,
septic workup and intravenous antibiotics pending
culture findings. There are no accepted standard cri-
teria for evaluation of SBI risk in Taiwan. In this
study, we retrospectively examined a cohort of febrile
infants (< 3 months of age) to assess significant SBI
risk factors and hence develop and validate a model
for predicting SBI.
Methods
Consecutive infants younger than 3 months of age
who were admitted with fever between August 2003
and August 2004 were included for analysis. Fever
was indicated when rectal temperature was ≥ 38°C.
Those who were premature (born before 36 weeks of
gestation) or who had underlying diseases (such as
congenital heart disease, bronchopulmonary dyspla-
sia, chronic lung disease, immunodeficiency, chromo-
some anomalies or congenital gastrointestinal tract
anomalies) were excluded. Infants with hyperbiliru-
binemia and those who exhibited an antenatal setup
for sepsis (premature rupture of membranes, maternal
fever or peripartum antibiotics) were also excluded.
After admission, septic workup included a com-
plete blood count, serum CRP analysis, urinalysis col-
lected by urine bag, urine culture that was collected
by suprapubic puncture or urinary catheterization,
and blood cultures. Physical appearance was also
graded by the attending pediatrician as either well or
poor. Poor physical appearance was indicated by any
of the following: decreased oral feeding, irritability, 
or any sign of dehydration (skin turgor, depressed
fontanel, decrease urine output). If patients had diar-
rhea, bedside stool smears were obtained and imme-
diately examined for WBC count. Chest X-rays were
performed and evaluated if respiratory symptoms 
were apparent. Lumbar puncture and cerebrospinal
fluid (CSF) analysis were performed if there was sus-
picion of central nervous system infection (i.e. seizure,
irritability or drowsiness, bulging fontanel, toxic
appearance with no infection focus). Each infant was
treated with intravenous antibiotics while awaiting
culture results.
SBI included bacteremia, bacterial meningitis, 
osteomyelitis, bacterial gastroenterocolitis, lobar
pneumonia, and urinary tract infection. Urinary tract
infection was defined as a single pathogen with a
colony count exceeding 105/mL.
An IMMAGE Immunochemistry System (Beckman
Coulter, Fullerton, CA, USA) was used to measure
CRP in serum samples. The sensitivity of the test was
0.1 mg/dL, and the measurable range was from
0.1 mg/dL to 96 mg/dL.
Statistical analysis
Data are expressed as mean ± standard deviation or
median (range) for continuous variables, and as num-
ber (%) for categorical variables. Differences between
infants who did and did not have SBI were compared
using Student’s t test or the Wilcoxon rank sum test
for continuous data, and the χ2 or Fisher’s exact test for
categorical data. To determine the criteria for predict-
ing SBI, 70% of the patients (n = 99) were randomly
selected by simple random sampling for multivariate
logistic regression. The estimated probabilities of hav-
ing an SBI were obtained from the fitted model, and
a cut-off point was selected for determining whether
patients had SBI or not. The fitted regression model
and the cut-off probability were then applied to the
remainder of the patients for validation. All analyses
were performed using SAS version 8.0 (SAS Institute
Inc., Cary, NC, USA). A p value < 0.05 was considered
to be statistically significant.
Results
The demographics and clinical features of infants who
did and did not have SBI are presented in Table 1. 
A total of 135 febrile infants younger than 3 months
of age were enrolled in the study; 34 (25.2%) were
subsequently found to have SBI. The incidence of SBI
was significantly higher in male infants and those older
than 29 days at admission (p < 0.01 and 0.04, respec-
tively, for both), while there was a decreased occur-
rence of SBI in infants who appeared well (p = 0.03).
Infants with WBC count < 5,000/mm3 or > 15,000/
mm3 were more likely to have SBI than those with
WBC count of 5,000–15,000/mm3 (p = 0.02). Infants
with SBI had significantly higher levels of CRP and
spun urine WBC count (p < 0.01 for both). With
regards to the positive cultures, 82% were Escherichia
coli. Klebsiella pneumoniae was detected in 2 infants.
The 2 positive CSF cultures were group B streptococ-
cus and Coxsackievirus. No non-SBI infant had posi-
tive blood or urine cultures. The single non-SBI infant
(CSF viral culture revealed Coxsackie virus) who
exhibited a positive CSF finding was diagnosed with
J Chin Med Assoc • October 2009 • Vol 72 • No 10522
C.J. Chen, et al
aseptic meningitis (indicated if any of the following 
4 findings was present: elevated CSF cell counts,
increased intracranial pressure, positive CSF viral cul-
ture or positive electroencephalogram finding).
Sex, spun urine WBC count, and CRP were found
to be significantly related to SBI (Table 2). Male infants,
those with spun urine WBC count > 10 per high-
powered field (HPF; 400×), and CRP levels > 3.6 mg/
L had significantly increased risk of SBI (p < 0.05 
for all).
An estimated probability of SBI of 0.265 was
selected as the cut-off point for predicting SBI as the
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Table 1. Comparison of the demographic and clinical features of non-SBI and SBI patients
Total (n = 135) Non-SBI (n = 101) SBI (n = 34) p
Age (d)* 0.04||
< 29 60 (44.44%) 50 (49.50%) 10 (29.41%)
≥ 29 75 (55.56%) 51 (50.50%) 24 (70.59%)
Sex† < 0.01||
Male 90 (66.67%) 60 (59.41%) 30 (88.24%)
Female 45 (33.33%) 41 (40.59%) 4 (11.76%)
Appearance* 0.03||
Well 105 (77.78%) 83 (82.18%) 22 (64.71%)
Poor 30 (22.22%) 18 (17.82%) 12 (35.29%)
Previously healthy –
Yes 135 (100.00%) 101 (100.00%) 34 (100.00%)
No 0 0 0
Focal lesion† 0.17
Yes 108 (80.00%) 78 (77.23%) 30 (88.24%)
No 27 (20.00%) 23 (22.77%) 4 (11.76%)
WBC (count/mm3)*
5,000–15,000 97 (71.85%) 78 (77.23%) 19 (55.88%) 0.02||
< 5,000 or > 15,000 38 (28.15%) 23 (22.77%) 15 (44.12%)
Bands (%)‡ 0 (0, 6) 0 (0, 5) 0 (0, 6) 0.13
Segments (%)§ 47.80 ± 18.34 46.44 ± 16.91 51.85 ± 21.83 0.14
Lymphocytes (%)§ 40.28 ± 16.64 41.32 ± 15.79 37.20 ± 18.87 0.21
Monocytes (%)‡ 9 (1, 30) 10.0 (1.9, 30.0) 8 (1, 21) 0.10
CRP (mg/dL)† < 0.01||
< 3.6 67 (49.63%) 61 (60.4%) 6 (17.65%)
≥ 3.6 68 (50.37%) 40 (39.6%) 28 (82.35%)
Urine routine WBC‡ 2.0 (0.2, 25.0) 2.0 (0.2, 25.0) 2.5 (1.0, 16.0) 0.25
Spun urine WBC count† < 0.01||
< 10/HPF (400×) 109 (80.74%) 95 (94.06%) 14 (41.18%)
≥ 10/HPF (400×) 26 (19.26%) 6 (5.94%) 20 (58.82%)
Urine bacterial culture† < 0.01||
Positive 27 (20.00%) 0 (0.00%) 27 (79.41%)
Negative 108 (80.00%) 101 (100%) 7 (20.59%)
Blood bacterial culture† 0.01||
Positive 3 (2.22%) 0 3 (8.82%)
Negative 132 (97.78%) 101 (100.00%) 31 (91.18%)
CXR† 0.45
Positive 10 (7.41%) 9 (8.91%) 1 (2.94%)
Negative 125 (92.59%) 92 (91.09%) 33 (97.06%)
CSF bacterial/viral culture† < 0.01||
Positive 6 (4.44%) 1 (0.99%) 5 (14.71%)
Negative 129 (95.56%) 100 (99.01%) 29 (85.29%)
*c2 test or †Fisher’s exact test for categorical variables; ‡Wilcoxon rank sum test or §Student’s t test for continuous variables; ||p < 0.05. SBI = serious bacterial
infection; WBC = white blood cell; CRP = C-reactive protein; HPF = high-powered field; CXR = chest X-ray; CSF = cerebrospinal fluid.
specificity was approximately equal to the sensitivity
at this point. Infants with a probability ≥ 0.265 were
considered to be at high risk for SBI. Those with prob-
abilities below this value were considered to have low
risk of SBI. Sensitivity and specificity were 80% and
81.1%, respectively (Table 3). To validate the criteria
for predicting SBI, the fitted model and cut-off prob-
abilities were applied to the 36 other patients not
used for construction of the model. Both sensitivity
and specificity were 77.8%.
Discussion
There have been many studies published that report low
risk factors for SBI in young febrile infants. Despite
this, there exists no uniformly accepted strategy for
identifying such infants. In this study, we retrospec-
tively examined infants younger than 3 months of age
who were admitted with fever for SBI risk factors. We
determined that sex, spun urine WBC count and serum
CRP concentration were predictive of SBI. We further
utilized these variables to construct and validate a
model for predicting SBI.
As already noted, numerous studies have reported
risk factors for SBI in infants. The Rochester criteria
and the Philadelphia protocol are 2 popular assess-
ment methods for predicting low risk of SBI. These
methods include a range of variables including physi-
cal appearance, age, previous health and WBC counts
in serum, spun urine, CSF and stool for assessment. 
A recent study by Garra and colleagues utilized both
assessment techniques to determine low SBI risk in a
cohort of infants aged ≤ 56 days.18 It was found that
the negative predictive values (NPV) for SBI in these
infants were 97.1% and 97.3% for the Philadelphia
protocol and Rochester criteria, respectively. A study
conducted by Bachur and Harper incorporated uri-
nalysis, WBC count, temperature and age as risk fac-
tors for SBI in infants younger than 90 days of age
and found an NPV of 98.3%.6 Another large study
conducted in Taiwan yielded an NPV of 99.2% for
SBI, where risk parameters included physical exami-
nation results, WBC count, differential count, urinal-
ysis, stool exam and CRP levels.5 While all of these
J Chin Med Assoc • October 2009 • Vol 72 • No 10524
C.J. Chen, et al
Table 2. Association between risk factors and SBI for 99 randomly selected patients (training sample) by multivariate logistic 
regression*
OR 95% CI p
Age (d) 0.41
≥ 29 0.52 (0.11–2.41)








< 5,000 or > 15,000 0.90 (0.20–4.09)
5,000–15,000 Reference –
CRP (mg/dL) < 0.01†
≥ 3.6 9.54 (1.81–50.31)
< 3.6 Reference –
Spun urine WBC count < 0.01†
≥ 10/HPF (400×) 26.20 (5.35–128.25)
< 10/HPF (400×) Reference –
*Positive likelihood ratio was 4.23, and negative likelihood ratio was 0.25; †significantly related to SBI, p < 0.05. SBI = serious bacterial infection; OR = odds
ratio; CI = confidence interval; WBC = white blood cell; CRP = C-reactive protein.
Table 3. Variations of probability for several cutoffs








studies indicate that it is possible to achieve high rates
of selectivity with respect to identifying infants at 
low risk for SBI, none could discriminate with 100%
certainty.
Approximately one quarter of the infants included
in our study were found to have SBI. Although at 
the upper end, this level of occurrence falls within 
the range of values reported in the general litera-
ture.1–8 We determined that the incidence of SBI was
higher in infants who were male, in those older than
29 days, with poor appearance, WBC count outside
of the range 5,000–15,000 counts/mm3, and those
with higher CRP levels and spun urine WBC counts
≥ 10/HPF (400×). On further multivariate regression
analysis, it was determined that sex, spun urine WBC
count and serum CRP concentration were signifi-
cantly related to SBI. Other studies have also found/
utilized these measures to indicate SBI risk. The CRP
cut-off of 3.6 mg/L utilized in our study is signifi-
cantly lower than those reported in a number of other
studies.10,15,19 However, we have found that the nor-
mal CRP range is 0–5 mg/L. The spun urine WBC
count cut-off of ≥ 10/HPF (400×) is the same as
used in both the Rochester criteria and Philadelphia
protocol.3,13 To our knowledge, no other study has
found sex to be a significant risk factor for SBI. This
may simply be a reflection of the relatively small study
sample size or the fact that urinary tract infections 
are more common in uncircumcised male infants.
Using the 3 significant risk factors of sex, CRP and
spun urine WBC count, a cut-off probability for SBI
was selected where infants with values below this prob-
ability were considered to have a low risk of SBI, and
those above a high risk. This model was employed to
assess SBI risk in a small cohort of febrile infants and
found to be accurate in predicting SBI status. Hence,
it would appear that sex, serum CRP concentrations
and spun urine WBC count can be successfully em-
ployed to classify infants younger than 3 months of
age as being at high or low risk for SBI.
Several studies have reported on the treatment 
of febrile infants at low risk for SBI as determined by
various criteria. Baker et al reported that it is safe 
for low risk infants, aged 29–56 days, to be treated 
as outpatients and without antibiotics.13 A study by
Baskin and colleagues suggested that close outpatient
monitoring with intramuscular ceftriaxone treatment
is a successful alternative to hospital admission for in-
fants aged 28–89 days.2 Several other studies have
suggested that low-risk infants should be hospitalized
either without antibiotic treatment5 or without anti-
biotic treatment until culture findings are available.4,20
The latter treatment paradigm was not associated
with any increase in morbidity when compared to
infants in whom antibiotic treatment was initiated on
admission. Hence, there is no consensus as to how
low-risk SBI infants with fever should be treated
assuming immediate antibiotic therapy is not insti-
gated. Home care with vigilant parental supervision
would appear to be the ideal option, but further study
is needed to determine the optimal balance between
infant and parental comfort and infant health.
Certainly, a major limitation of this study is the
small sample size. With this in mind, we suggest that
larger-scale, multicenter, randomized, controlled stud-
ies are warranted to further validate the criteria uti-
lized in this study for predicting SBI status. It is also
necessary to determine whether or not these criteria
can be successfully applied in infants within a specific,
less broad age range, i.e. < 1 month old, > 3 months
old, and so on.
In conclusion, we have studied a group of febrile
infants less than 3 months old, and found that sex,
serum CRP concentration and spun urine WBC count
could be utilized to predict SBI with a high degree of
sensitivity and specificity. As our study population was
relatively small, additional studies are warranted to
further validate this assessment model.
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